These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10388799)

  • 1. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
    Camp SJ; Stevenson VL; Thompson AJ; Miller DH; Borras C; Auriacombe S; Brochet B; Falautano M; Filippi M; Hérissé-Dulo L; Montalban X; Parrcira E; Polman CH; De Sa J; Langdon DW
    Brain; 1999 Jul; 122 ( Pt 7)():1341-8. PubMed ID: 10388799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and transitional progressive MS: a clinical and MRI cross-sectional study.
    Stevenson VL; Miller DH; Rovaris M; Barkhof F; Brochet B; Dousset V; Dousset V; Filippi M; Montalban X; Polman CH; Rovira A; de Sa J; Thompson AJ
    Neurology; 1999 Mar; 52(4):839-45. PubMed ID: 10078736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of cognition in primary progressive multiple sclerosis.
    Camp SJ; Stevenson VL; Thompson AJ; Ingle GT; Miller DH; Borras C; Brochet B; Dousset V; Falautano M; Filippi M; Kalkers NF; Montalban X; Polman CH; Langdon DW
    Brain; 2005 Dec; 128(Pt 12):2891-8. PubMed ID: 16049040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.
    De Meo E; Portaccio E; Giorgio A; Ruano L; Goretti B; Niccolai C; Patti F; Chisari CG; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Simone M; Viterbo RG; Bonacchi R; Rocca MA; De Stefano N; Filippi M; Amato MP
    JAMA Neurol; 2021 Apr; 78(4):414-425. PubMed ID: 33393981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis.
    Foong J; Rozewicz L; Chong WK; Thompson AJ; Miller DH; Ron MA
    J Neurol; 2000 Feb; 247(2):97-101. PubMed ID: 10751110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.
    Hohol MJ; Guttmann CR; Orav J; Mackin GA; Kikinis R; Khoury SJ; Jolesz FA; Weiner HL
    Arch Neurol; 1997 Aug; 54(8):1018-25. PubMed ID: 9267977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
    Nunnari D; De Cola MC; D'Aleo G; Rifici C; Russo M; Sessa E; Bramanti P; Marino S
    Biomed Res Int; 2015; 2015():519785. PubMed ID: 25861633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.
    Sperling RA; Guttmann CR; Hohol MJ; Warfield SK; Jakab M; Parente M; Diamond EL; Daffner KR; Olek MJ; Orav EJ; Kikinis R; Jolesz FA; Weiner HL
    Arch Neurol; 2001 Jan; 58(1):115-21. PubMed ID: 11176944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
    Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
    Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Feinstein A; Meza C; Stefan C; Staines RW
    Brain; 2019 Sep; 142(9):2800-2812. PubMed ID: 31363742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year follow up study of primary and transitional progressive multiple sclerosis.
    Stevenson VL; Miller DH; Leary SM; Rovaris M; Barkhof F; Brochet B; Dousset V; Filippi M; Hintzen R; Montalban X; Polman CH; Rovira A; de Sa J; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):713-8. PubMed ID: 10811693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
    Tur C; Penny S; Khaleeli Z; Altmann DR; Cipolotti L; Ron M; Thompson AJ; Ciccarelli O
    Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.